Quantum Discovery Labs http://q-pharm.com The drug discovery company Fri, 03 Feb 2012 10:47:43 +0000 en hourly 1 http://wordpress.org/?v=3.2.1 In-vitro study of DLX5 Ligands http://q-pharm.com/2012/01/in-vitro-study-of-dlx5-ligands/ http://q-pharm.com/2012/01/in-vitro-study-of-dlx5-ligands/#comments Thu, 26 Jan 2012 14:44:09 +0000 Gulnara Yamanbaeva http://q-pharm.com/?p=563
  • High Throughput Screening of Transcription factor DLX5
  • Experimental siRNA complex uptake without transfection reagents
  • Docking validation study: PDK1-kinase (oncology)
    • Related posts brought to you by Yet Another Related Posts Plugin.]]>     http://q-pharm.com/2012/01/in-vitro-study-of-dlx5-ligands/feed/ 0     High Throughput Screening of Transcription factor DLX5 http://q-pharm.com/2012/01/high-throughput-screening-of-transcription-factor-dlx5/ http://q-pharm.com/2012/01/high-throughput-screening-of-transcription-factor-dlx5/#comments Thu, 26 Jan 2012 14:23:10 +0000 Gulnara Yamanbaeva http://q-pharm.com/?p=740
  • In-vitro study of DLX5 Ligands
  • Virtual High Throughput Screening
  • Application of a novel in silico high throughput screen to identify selective inhibitors for protein–protein interactions
  • Experimental siRNA complex uptake without transfection reagents
  • Protein Flexibility and False Positives detection.
    • Related posts brought to you by Yet Another Related Posts Plugin.]]>     http://q-pharm.com/2012/01/high-throughput-screening-of-transcription-factor-dlx5/feed/ 0     MA/p17 HIV matrix protein is a promising target for drug discovery http://q-pharm.com/2011/12/map17-hiv-matrix-protein-is-a-promising-target-for-drug-discovery/ http://q-pharm.com/2011/12/map17-hiv-matrix-protein-is-a-promising-target-for-drug-discovery/#comments Tue, 20 Dec 2011 14:00:43 +0000 Peter Fedichev, Quantum CTO http://q-pharm.com/?p=385
  • New MA/p17 matrix protein inhibitors display broad antiviral activity against multiple subtypes of HIV-1
  • Influenza matrix M1 protein inhibitors show promising in-vivo efficacy
  • Virtual Identification of a Protein Target
  • Drug resistance: evolution in action
  • Quantum and Tibotec Pharmaceuticals enter antiviral drug discovery collabortaion.
    • Related posts brought to you by Yet Another Related Posts Plugin.]]>     http://q-pharm.com/2011/12/map17-hiv-matrix-protein-is-a-promising-target-for-drug-discovery/feed/ 0     Experimental evidence of the ferroelectric phase transition near the $λ-$point in liquid water http://q-pharm.com/2011/08/experimental-evidence-of-the-ferroelectric-phase-transition-near-the-%ce%bb-point-in-liquid-water/ http://q-pharm.com/2011/08/experimental-evidence-of-the-ferroelectric-phase-transition-near-the-%ce%bb-point-in-liquid-water/#comments Thu, 25 Aug 2011 16:34:31 +0000 Peter Fedichev, Quantum CTO http://q-pharm.com/?p=443
  • Ferro-electric phase transition in a polar liquid and the nature of lambda-transition in supercooled water
  • Ferro-electric phase transition in a polar liquid and the nature of \lambda-transition in supercooled water
  • The nature of percolation phase transition in films of hydration water around immersed bodies.
  • Water polarization and density profiles at a gas-liquid interface
  • Spontaneous polarization of a polar liquid next to nano-scale impurities
    • Related posts brought to you by Yet Another Related Posts Plugin.]]>     http://q-pharm.com/2011/08/experimental-evidence-of-the-ferroelectric-phase-transition-near-the-%ce%bb-point-in-liquid-water/feed/ 0     Structure-based drug design of a new chemical class of small molecules active against influenza A nucleoprotein in vitro and in vivo http://q-pharm.com/2011/08/structure-based-drug-design-of-a-new-chemical-class-of-small-molecules-active-against-influenza-a-nucleoprotein-in-vitro-and-in-vivo/ http://q-pharm.com/2011/08/structure-based-drug-design-of-a-new-chemical-class-of-small-molecules-active-against-influenza-a-nucleoprotein-in-vitro-and-in-vivo/#comments Tue, 09 Aug 2011 06:18:11 +0000 Peter Fedichev, Quantum CTO http://q-pharm.com/?p=419
  • Influenza matrix M1 protein inhibitors show promising in-vivo efficacy
  • Quantum Discovery Services
  • Beefing up the pipeline: new leads against influenza virus identified
  • From binding data to pharmacokinetics: a novel approach to active drug absorbtion prediction
  • Drug design, drug development, bioinformatics and preclinical services
    • Related posts brought to you by Yet Another Related Posts Plugin.]]>     http://q-pharm.com/2011/08/structure-based-drug-design-of-a-new-chemical-class-of-small-molecules-active-against-influenza-a-nucleoprotein-in-vitro-and-in-vivo/feed/ 0